It is believed that the anti-infl ammatory activity of medicines is closely related to their antioxidant activity. However, in clinical practice rigorous evidence-based medicine approach fails to reveal important effects of antioxidants on patient important outcomes in infl ammatory disorders, as has been shown by a number of Cochrane reviews [1] [2] [3] .
S68
dimephosphone, ephorane, and prednisone exerted anti-infl ammatory effect decreasing the volume of left hind paws by 45%, 46% и 27% respectively on the 40th day of experiment. Mephoprane did not affect the primary infl ammatory response to the Freund's adjuvant (rats' left hind paws), however it reduced the volume of the contralateral right paw (secondary arthritis) by 90% on the 20th day of the experiement. This ant-infl ammatory effect was accompanied by documented antioxidant activity in case of dimephosphone, ephorane, prednisolone, but not mephoprane. Dimephosphone reduced the levels of lipid peroxidation products in rats blood by 46% (DC) and by 25% (MDA). Ephorane also reduced the levels of lipid peroxidation products in the blood by 46% (DC) and by 25% (MDA), increasing the level of glutathione by nearly half, both the total and the reduced form. Prednisolone reduced the level of lipid peroxidation products in blood by 61% (DC), but not the TBA-interacting products. Mefopran did not affect the blood level of lipid peroxidation products. Xymedon and etidronate showed no antiinfl ammatory effect. Xymedon demonstrated anti-oxidant properties, decreasing the blood levels of lipid peroxidation products, while etidronate seemed to behave in pro-oxidant mode, increasing the blood levels of lipid peroxidation products.
CONCLUSIONS:
The effects of studied agents on the intensity of infl ammation and lipid peroxidation were inconsistent. The results of the study did not show a clear link between anti-infl ammatory and anti-oxidant activity. Further research in potential anti-infl ammatory activity of new drugs exhibiting antioxidant properties needs to be done before recommending their use in clinical practice.
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